LOGEX Group

Turning data into better healthcare

Company details

Year of Investment

2018

Location

Northern Europe

Revenue (2019)

NA

Sector

Healthcare analytics

Employees

322

Investment Themes

Changing Demographics

Contact

If you want to know more about LOGEX Group please contact Anna Ryrberg at: anna.ryrberg@summaequity.com

Logex at a glance

LOGEX is the European leader in advanced analytics for healthcare, serving providers, payors and authorities. The company has the most comprehensiveproduct portfolio in its field in Europe, and the broadest geographical reach.
The company operates three main business units:

  • Financial analytics (e.g., cost, resource allocation, planning),
  • Outcomes analytics (e.g., healthcare quality outcome measurement
    and benchmarking)
  • Life sciences (real world evidence data and analytics)

 

Key developments in 2020

LOGEX delivered solid results in 2020 despite Covid-19 disruptions. A large integration effort has been done in 2019 and 2020, resulting in a reshaped business, organization, strategy, and product that has increased clarity on focus and priorities.

In 2020, LOGEX launched and rolled out the next generation Financial Analytics platform, a key milestone for the international growth plan. The company also progressed a key partnership with ICHOM (International Consortium for Health Outcomes Measurement), which was secured in Q1 2021.

Moreover, LOGEX strengthened its position in Financial Analytics in the Nordics through the acquisition of Analysesentret. The company also built further international presence with the partnership and a minority investment in the Spanish outcome analytics company HopesOnHealth.

Impact Dimensions

The challenges we face

Healthcare systems globally are under pressure from increasing costs, whilst the need to improve quality is continuously increasing. There is a lack of transparency in both outcomes and costs in healthcare, which makes it very difficult to fully comprehend and address these challenges.

 

%
Share of GDP spent on healthcare in the OECD
2-x
variation in outcome rates across OECD countries

 

What is the outcome?

The LOGEX offers a comprehensive software portfolio to support a holistic approach to improve healthcare through advanced analytics. It also enables stakeholders in the healthcare system to transition towards more quality-centric and cost-conscious healthcare through an unprecedented level of clarity on the performance of outcomes and costs.

 

Who are the stakeholders?

LOGEX' core geographical markets are the Netherlands, Sweden, Finland, Norway, and the UK. The company offers advanced analytics solutions that transform data into actionable insight, bringing clarity to decisions that lead to improved outcomes at la lower cost. Thus, LOGEX' solutions benefit the healthcare system as a whole (including payors, providers and patients) by enabling a transition towards more quality-centered and cost-efficient care.

 

How big is the effect, and does it last?

More than 600 providers are using LOGEX' platform and more than 22 million unique patients have been impacted by insights derived from the Group's analytic tools. LOGEX Group's solutions are supporting over €100Bn in healthcare funding decisions annually, demonstrating the effect that LOGEX Group has on its stakeholders.

 

If LOGEX didn’t exist…

Without LOGEX' solutions, healthcare providers would not have the same level of clarity on the relative performance of their operations and data-driven tools allowing them to effectively manage costs and quality of care. This could negatively impact the quality patients receive and thereby lead to suboptimal outcomes in terms of lower quality at a higher cost, and greater variability.

 

Impact risk: what can go wrong?

The pace of transformation of healthcare systems towards quality-centric care and value-based healthcare presents a potential risk for LOGEX. While there is evidence of a change starting to emerge, we are yet to reach the real inflection point for more rapid change. This is primarily a risk related to the less mature products in the portfolio focused on value-based healthcare. Another risk LOGEX face is related to data security and privacy. The company has invested heavily to maintain the highest security standards and has obtained several internationally recognized certifications. The total impact that LOGEX will achieve is also dependent on its ability to scale the technology and offering to new geographical markets.

Year of Investment

2018

Revenue (2019)

NA

Employees

322

Investment Themes

Changing Demographics

Sector

Healthcare analytics

Location

Northern Europe

Contact

If you want to know more about LOGEX Group please contact Anna Ryrberg at: anna.ryrberg@summaequity.com

Website

Video

SDG Alignment
SDG Wheel
SDG 3
KPI reporting
SDG 3

HEALTHCARE INSTITUTIONS USING LOGEX TOOLS

2020
600
SDG 3

HEALTHCARE FUNDING AFFECTED (EUR)

2020
100 Bn
SDG 3

PATIENTS IMPACTED

2020
22m

Learn more about Logex Group

LOGEX, Ivbar, and Prodacapo join forces to create a European market leader in advanced costing and quality analytics for healthcare

With the aim of strengthening their ability to inform and support sustainable quality improvements, transparency and efficiency in healthcare LOGEX, Ivbar, and Prodacapo have decided to join forces through the new LOGEX Group. This will create a European market leader in advanced software for analysing outcomes and costs in healthcare. Today, the three companies all…

Read the story

LOGEX, Ivbar, and Prodacapo join forces to create a European market leader in advanced costing and quality analytics for healthcare

With the aim of strengthening their ability to inform and support sustainable quality improvements, transparency and efficiency in healthcare LOGEX, Ivbar, and Prodacapo have decided to join forces through the new LOGEX Group. This will create a European market leader in advanced software for analysing outcomes and costs in healthcare. Today, the three companies all...
Learn more